Divi's Laboratories Limited (DIVISLAB.BO)

INR 5849.2

(0.02%)

Total Debt Summary of Divi's Laboratories Limited

  • Divi's Laboratories Limited's latest annual total debt in 2023 was 30 Million INR , down -7.98% from previous year.
  • Divi's Laboratories Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Divi's Laboratories Limited reported annual total debt of 32.6 Million INR in 2022, down -11.65% from previous year.
  • Divi's Laboratories Limited reported annual total debt of 36.9 Million INR in 2021, down -23.6% from previous year.
  • Divi's Laboratories Limited reported quarterly total debt of 30 Million INR for 2023 Q4, down 0.0% from previous quarter.
  • Divi's Laboratories Limited reported quarterly total debt of 30 Million INR for 2023 FY, down -7.98% from previous quarter.

Annual Total Debt Chart of Divi's Laboratories Limited (2023 - 2005)

Historical Annual Total Debt of Divi's Laboratories Limited (2023 - 2005)

Year Total Debt Total Debt Growth
2023 30 Million INR -7.98%
2022 32.6 Million INR -11.65%
2021 36.9 Million INR -23.6%
2020 48.3 Million INR -87.57%
2019 388.5 Million INR -63.21%
2018 1.05 Billion INR 67.33%
2017 631.1 Million INR 76.58%
2016 357.4 Million INR -14.91%
2015 420.04 Million INR 64.26%
2014 255.71 Million INR 51.55%
2013 168.73 Million INR -45.52%
2012 309.71 Million INR -41.44%
2011 528.85 Million INR 185.17%
2010 185.45 Million INR -43.54%
2009 328.48 Million INR -37.6%
2008 526.39 Million INR -78.29%
2007 2.42 Billion INR 57.52%
2006 1.53 Billion INR 2.51%
2005 1.5 Billion INR 0.0%

Peer Total Debt Comparison of Divi's Laboratories Limited

Name Total Debt Total Debt Difference
Ajanta Pharma Limited 352.8 Million INR 91.497%
Amrutanjan Health Care Limited 17.28 Million INR -73.581%
Sigachi Industries Limited 1.43 Billion INR 97.903%
Bal Pharma Limited 1.39 Billion INR 97.852%
Ind-Swift Laboratories Limited 166.21 Million INR 81.951%
Medico Remedies Limited 80.5 Million INR 62.735%
Lasa Supergenerics Limited 220.76 Million INR 86.411%
Venus Remedies Limited 413.3 Million INR 92.741%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 95.094%
Alpa Laboratories Limited 52.46 Million INR 42.819%
Nectar Lifesciences Limited 6.35 Billion INR 99.528%
Shilpa Medicare Limited 9.37 Billion INR 99.68%
Aarti Drugs Limited 5.64 Billion INR 99.468%
Lupin Limited 29.21 Billion INR 99.897%
Aurobindo Pharma Limited 66.47 Billion INR 99.955%
Zydus Lifesciences Limited 8.04 Billion INR 99.627%
Windlas Biotech Limited 36.41 Million INR 17.605%
Suven Life Sciences Limited 7.09 Million INR -322.714%
Eris Lifesciences Limited 27.81 Billion INR 99.892%
Valiant Laboratories Limited 767.08 Million INR 96.089%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 99.206%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.703%
Ipca Laboratories Limited 14.38 Billion INR 99.791%
Bliss GVS Pharma Limited 998.4 Million INR 96.995%
Achyut Healthcare Limited - INR -Infinity%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.908%
Bajaj HealthCare Limited 3.32 Billion INR 99.099%
RPG Life Sciences Limited - INR -Infinity%
Mankind Pharma Limited 2.07 Billion INR 98.552%
Laurus Labs Limited 25.77 Billion INR 99.884%
Piramal Pharma Limited 47.1 Billion INR 99.936%
Syncom Formulations (India) Limited 724.86 Million INR 95.861%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.925%
Alembic Pharmaceuticals Limited 5.13 Billion INR 99.415%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.756%
Unichem Laboratories Limited 2.47 Billion INR 98.788%
Sequent Scientific Limited 4.87 Billion INR 99.385%
Novartis India Limited 69.7 Million INR 56.958%
Wanbury Limited 1.16 Billion INR 97.425%
Suven Pharmaceuticals Limited 649.96 Million INR 95.384%
Wockhardt Limited 23.56 Billion INR 99.873%
Themis Medicare Limited 957.92 Million INR 96.868%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR 66.447%
Jubilant Pharmova Limited 36.64 Billion INR 99.918%
Glenmark Life Sciences Limited 171.48 Million INR 82.505%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.85%
NATCO Pharma Limited 3.71 Billion INR 99.192%
Gufic Biosciences Limited 3.32 Billion INR 99.099%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 90.842%
Ind-Swift Limited 10.13 Billion INR 99.704%
Procter & Gamble Health Limited 95.6 Million INR 68.619%
FDC Limited 205.18 Million INR 85.379%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 98.449%
Granules India Limited 13.15 Billion INR 99.772%
Medicamen Biotech Limited 308.17 Million INR 90.265%
Alkem Laboratories Limited 14.18 Billion INR 99.788%
AstraZeneca Pharma India Limited 45.98 Million INR 34.757%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -583.527%
Brooks Laboratories Limited 56.41 Million INR 46.826%
Megasoft Limited 1.47 Billion INR 97.96%
ZIM Laboratories Limited 1.08 Billion INR 97.243%
Strides Pharma Science Limited 25.16 Billion INR 99.881%
Neuland Laboratories Limited 953.89 Million INR 96.855%
Morepen Laboratories Limited 289.99 Million INR 89.655%
Hikal Limited 8.17 Billion INR 99.633%
Indoco Remedies Limited 6.71 Billion INR 99.554%
Aarti Pharmalabs Limited 2.85 Billion INR 98.948%
Kilitch Drugs (India) Limited 316.46 Million INR 90.52%
Mangalam Drugs & Organics Limited 984.92 Million INR 96.954%
Hester Biosciences Limited 2.44 Billion INR 98.772%